Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Verweij

Showing results (161-170 of 655) with videos related to

Pageof 66
Sort By:
International Journal for Parasitology|March 8, 2000
PCR assay for the specific amplification of Oesophagostomum bifurcum DNA from human faecesJ J Verweij, A M Polderman, M C Wimmenhove, et al.
Journal of Chromatography|June 2, 1993
Sensitive isocratic high-performance liquid chromatographic determination of a novel indoloquinone cytotoxic drug (EO9) in human plasma and urineJ H Schellens, W Loos, J H Beijnen, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1988
A prospective study on the dose dependency of cardiotoxicity induced by mitomycin CJ Verweij, A J Funke-Küpper, G J Teule, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2008
Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-upP G Casali, L Jost, S Sleijfer, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1987
Cyclophosphamide, hexamethylmelamine, adriamycin and cisplatin combination chemotherapy in mixed mesodermal sarcoma of the female genital tractR L Jansen, M E van der Burg, J Verweij, et al.
Prenatal Diagnosis|November 28, 2024
Navigating the Ethical Landscape of the Artificial Placenta: A Systematic ReviewAlice Cavolo, Angret de Boer, Lien De Proost, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2001
Mechanism-based pharmacokinetic model for paclitaxelA Henningsson, M O Karlsson, L Viganò, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
Topotecan lacks third space sequestrationH Gelderblom, W J Loos, J Verweij, et al.
Gut|December 1, 1990
Strongyloides stercoralis associated with a bleeding gastric ulcerA Dees, P L Batenburg, H M Umar, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Selection of large and objectively measurable target lesions in EORTC phase II trials: impact on recruitment and response rate. EORTC Soft Tissue and Bone Sarcoma Group (STBSG)M Van Glabbeke, A T van Oosterom, W Steward, et al.
Pageof 66

Showing results (161-170 of 655) with videos related to

Sort By:
Pageof 66
International Journal for Parasitology|March 8, 2000
PCR assay for the specific amplification of Oesophagostomum bifurcum DNA from human faecesJ J Verweij, A M Polderman, M C Wimmenhove, et al.
Journal of Chromatography|June 2, 1993
Sensitive isocratic high-performance liquid chromatographic determination of a novel indoloquinone cytotoxic drug (EO9) in human plasma and urineJ H Schellens, W Loos, J H Beijnen, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1988
A prospective study on the dose dependency of cardiotoxicity induced by mitomycin CJ Verweij, A J Funke-Küpper, G J Teule, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2008
Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-upP G Casali, L Jost, S Sleijfer, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1987
Cyclophosphamide, hexamethylmelamine, adriamycin and cisplatin combination chemotherapy in mixed mesodermal sarcoma of the female genital tractR L Jansen, M E van der Burg, J Verweij, et al.
Prenatal Diagnosis|November 28, 2024
Navigating the Ethical Landscape of the Artificial Placenta: A Systematic ReviewAlice Cavolo, Angret de Boer, Lien De Proost, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2001
Mechanism-based pharmacokinetic model for paclitaxelA Henningsson, M O Karlsson, L Viganò, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
Topotecan lacks third space sequestrationH Gelderblom, W J Loos, J Verweij, et al.
Gut|December 1, 1990
Strongyloides stercoralis associated with a bleeding gastric ulcerA Dees, P L Batenburg, H M Umar, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Selection of large and objectively measurable target lesions in EORTC phase II trials: impact on recruitment and response rate. EORTC Soft Tissue and Bone Sarcoma Group (STBSG)M Van Glabbeke, A T van Oosterom, W Steward, et al.
Pageof 66